GreenLight Biosciences Closes Funding Round for Growth

GreenLight Biosciences has successfully closed a funding round as it transitions from a startup to a commercial entity. This financing is crucial for scaling its RNA crop protection solutions, marking a significant step in its operational growth.

Original excerpt: The former public company has closed a funding round as it transitions from a startup to a commercial organization…

Source: Triangle Business Journal